Heron Therapeutics | HRTX - 営業利益





営業利益 変化する 日付
ALKERMES USD -65.93M 17.65M 2026-06
Alnylam Pharmaceuticals USD 112.6M 24.99M 2026-06
Amarin USD -2.26M 564K 2025-12
ANI Pharmaceuticals USD 39.84M 1.13M 2026-06
Anika Therapeutics USD 646K 3.88M 2025-12
Arrowhead Research USD -170.09M 28.83M 2026-06
Eisai JPY 24.73B 35.04B 2026-06
Emergent BioSolutions USD -218M 69.9M 2023-06
GlaxoSmithKline GBP 2.6B 312M 2026-06
Heron Therapeutics USD 38K 3.83M 2025-12
Insmed USD -101.31M 98.97M 2026-06
Ligand Pharmaceuticals USD 56.62M 3.7M 2026-06
Merck USD 840M 2.72B 2026-06
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Neurocrine Biosciences USD 219.9M 5.3M 2026-06
Omeros USD -35.41M 23.75M 2024-09
Pacira USD 9.96M 5.33M 2026-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sangamo BioSciences USD -33.51M 12.77M 2024-06
Ultragenyx Pharmaceutical USD -75M 141M 2026-06
Veracyte USD 23.96M 4.88M 2026-06
Vertex Pharmaceuticals USD 1.27B 129.9M 2026-06